University of Las Palmas Gran Canaria
Hepatocellular adenomas associated with anabolic androgenic steroid abuse
Published in Health Business Week, June 24th, 2005
"AAS are used illicitly at high doses by bodybuilders. The misuse of these drugs is associated with serious adverse effects to the liver, including cellular adenomas and adenocarcinomas," scientists writing in the British Journal of Sports Medicine reported.
"We report two very different cases of adult male bodybuilders who developed hepatocellular adenomas following AAS abuse," explained L. Socas and colleagues, University of Las Palmas Gran Canaria.
"The first patient was asymptomatic but had two large liver lesions which...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2005-06-24)
More Articles from Health Business Week
- Administration Staff College India, Andhra Pradesh
HIV voluntary counseling and testing center efficiency lacking in Andhra Pradesh - Agilent Technologies, Inc.
Medical technology company names David Cooper as senior VP - Bio-Matrix Scientific Group, Inc.
Medical device firm clarifies announcement of stock distribution - Bio-logic Systems Corp.
Medical device maker reports 9% increase in sales - BioLok International, Inc.
Dental implant maker reports 38% increase in sales - Bioenvision
Biotech company to restate prior period financial statements - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
